(Q53730507)

English

Randomized open cross-over trial between Metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting

scientific article published on February 1, 1984

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

Randomized open cross-over trial between Metoclopramide (MCP) and dexamethazone (DXM) for the prevention of cisplatin-induced nausea and vomiting (English)

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

2

object named as

P. Pinnarò

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

author name string

F. Cognetti

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

P. Carlini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

E. M. Conti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

M. Cortese

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

C. F. Pollera

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6368241

9 October 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6368241

9 October 2023

publication date

1 February 1984

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

full work available at URL

https://api.elsevier.com/content/article/PII:0277537984901822?httpAccept=text/xml

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

https://api.elsevier.com/content/article/PII:0277537984901822?httpAccept=text/plain

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

European Journal of Cancer & Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

20

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

2

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

183-187

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

A Controlled Double-Blind Study of Trimethobenzamide, Prochlorperazine, and Placebo

2

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Controlled Studies of Metopimazine for the Treatment of Nausea and Vomiting

3

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Management of nausea and vomiting in the cancer patient

4

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

A CONTROLLED CLINICAL EVALUATION OF ANTIEMETIC DRUGS

5

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting

6

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Metoclopramide as an antiemetic in chemotherapy

8

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Unit activity from cat area postrema influenced by drugs

9

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Metoclopramide: a review of its pharmacological properties and clinical use

10

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Drug therapy. Metoclopramide

11

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

High-dose dexamethasone for prevention of cis-platin-induced vomiting

17

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Methylprednisolone as an antiemetic

18

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

The role of prostaglandins in the excessive nausea and vomiting after intravascular cis-platinum therapy

19

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Toxicity of cis-diamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration.

20

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Cis-diamminedichloroplatinum (II). A new anticancer drug

22

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Antagonism of cisplatin induced emesis in the dog

23

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Specific antiemetics for specific cancer chemotherapeutic agents: haloperidol versus benzquinamide

24

1 reference

10.1016/0277-5379(84)90182-2

https://api.crossref.org/works/10.1016/0277-5379(84)90182-2

9 October 2023

Identifiers

10.1016/0277-5379(84)90182-2

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 May 2018

http://europepmc.org/abstract/MED/6368241

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53730507&oldid=1989258695"